Literature DB >> 9330330

Transgenic methods to study chemokine function in lung and central nervous system.

S A Lira1, M E Fuentes, R M Strieter, S K Durham.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9330330     DOI: 10.1016/s0076-6879(97)87022-x

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  7 in total

Review 1.  Gene targeting of chemokines and their receptors.

Authors:  D M Slattery; N Gerard; C Gerard
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  The biology of chemokines and their receptors.

Authors:  Sergio A Lira; Glaucia C Furtado
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs.

Authors:  Shanshan Cai; Sanjay Batra; Sergio A Lira; Jay K Kolls; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

4.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

Authors:  T L Sørensen; M Tani; J Jensen; V Pierce; C Lucchinetti; V A Folcik; S Qin; J Rottman; F Sellebjerg; R M Strieter; J L Frederiksen; R M Ransohoff
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis.

Authors:  Terez Shea-Donohue; Karen Thomas; M Joshua Cody; Louis J Detolla; Karen M Kopydlowski; Masayuki Fukata; Sergio A Lira; Stefanie N Vogel
Journal:  Innate Immun       Date:  2008-04       Impact factor: 2.680

6.  Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.

Authors:  Esther Rodríguez-Gallego; Marta Riera-Borrull; Anna Hernández-Aguilera; Roger Mariné-Casadó; Anna Rull; Raúl Beltrán-Debón; Fedra Luciano-Mateo; Javier A Menendez; Alejandro Vazquez-Martin; Juan J Sirvent; Vicente Martín-Paredero; Angel L Corbí; Elena Sierra-Filardi; Gerard Aragonès; Anabel García-Heredia; Jordi Camps; Carlos Alonso-Villaverde; Jorge Joven
Journal:  Mediators Inflamm       Date:  2013-12-15       Impact factor: 4.711

7.  Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis.

Authors:  Jasper J van Gemst; Nathalie J H G Passmann; Angelique L W M M Rops; Toin H van Kuppevelt; Jo H Berden; Markus A Loeven; Ton J Rabelink; Bart Smeets; Johan van der Vlag
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.